Impact of overweight and obesity on cardiac benefit of antihypertensive treatment Academic Article uri icon

Overview

MeSH Major

  • Antihypertensive Agents
  • Hypertension
  • Obesity
  • Overweight

abstract

  • In hypertensive patients in the LIFE study, increased BMI was associated with less reduction of LV hypertrophy and less improvement in LV systolic function which may contribute to the observed higher cardiovascular event rate of treated hypertensive patients.

publication date

  • February 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.numecd.2011.03.008

PubMed ID

  • 21775111

Additional Document Info

start page

  • 122

end page

  • 9

volume

  • 23

number

  • 2